Clinical Trials Logo
  1. Home
  2. Candida
  3. NCT01077336

Clinical Outcomes in Candidemia Patients Based on in Vitro Susceptibility

Blood Stream Infections Clinical Trial

Official title:
Clinical Outcomes in Candidemia Patients Based on in Vitro Susceptibility

Clinical Trial Summary

Susceptibility testing is commonly employed in patients with bacterial infections in order to guide rational use of antibiotics; however, the use of antifungal susceptibility testing is limited due to lack of availability, costs, and delays in receiving results. The goals of antifungal susceptibility testing should mirror those of antibacterial susceptibility testing: to predict clinical response or failure. Additionally, susceptibility reports should be used as a guide for physicians when transitioning patients from parenteral to oral antifungal agents. Currently, it is unknown whether antifungal susceptibility testing impacts treatment decisions in hospitals that routinely perform Candida susceptibility testing. The purpose of this study is to evaluate the changes in antifungal treatment based on in vitro susceptibility reports and how these decisions affect mortality, recurrence of infection, and length of hospital stay in candidemia patients.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01077336
Study type Observational
Source University of Houston
Contact
Status Completed
Phase N/A
Start date January 2010
Completion date January 2011
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04874441 - Candida PCR Diagnosis Strategy in Patients From Intensive Care Units N/A
Recruiting NCT00697944 - Ambisome® Preemptive Treatment of Multiple Candida Colonization in Sepsis Patients Phase 4
Completed NCT00109525 - Early Diagnosis of Candidiasis in Premature Infants
Completed NCT05614726 - A Probiotic Blend Reduces Gastrointestinal Symptoms and Positively Impacts Microbiota Modulation in a Randomized Study N/A
Completed NCT00818584 - An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in Neonates Phase 1
Completed NCT00366223 - Changing Patterns of Candida Infections in Urban Medical Centers
Completed NCT03212729 - Antimicrobial Photodynamic Therapy Associated With the Conventional Endodontic Treatment: A Clinical and Microbiological Study N/A
Completed NCT00058682 - Anidulafungin Versus Fluconazole in the Treatment of Candidemia Phase 3